Alef Aragão

Alef Aragão

Auto-generated profile, based on publicly available information

Alef Aragão

Renal Diagnostics and Therapeutics Unit, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
EPEdson de Andrade Pessoa
Edson de Andrade Pessoa
MCMarcia Bastos Convento
Marcia Bastos Convento
BCBianca Castino
Bianca Castino
ALAla Moana Leme
Ala Moana Leme
AOAndréia Silva de Oliveira
Andréia Silva de Oliveira
FBFernanda Teixeira Borges
Fernanda Teixeira Borges
Several studies have demonstrated an important association between altered lipid metabolism and the development of kidney injury because of a high-fat diet. Fructose is also closely associated with renal injury. We opted for a combination of fructose and saturated fats in a diet (DH) that is a model known to induce renal damage in order to evaluate whether soy isoflavones could have promising use in the treatment of renal alterations. After two months of ingestion, there was an expansion of visceral fat, which was associated with long-term metabolic disorders, such as sustained hyperglycemia, insulin resistance, polyuria, dyslipidemia, and hypertension. Additionally, we found a decrease in renal blood flow and an increase in renal vascular resistance. Biochemical markers of chronic kidney disease were detected; there was an infiltration of inflammatory cells with an elevated expression of proinflammatory cytokines (tumor necrosis factor-α, interleukin (IL)-6, and IL-1β), the activation of the renin–angiotensin system, and oxidative/nitrosative stress. Notably, in rats exposed to the DH diet for 120 days, the concomitant treatment with isoflavones after 60 days was able to revert metabolic parameters, renal alterations, and oxidative/nitrosative stress. The beneficial effects of isoflavones in the kidney of the obese rats were found to be mediated by expression of peroxisome proliferator-activated receptor gamma (PPAR-γ).

1 February 2019 in Oncotarget
Verified
Journal Article
Open access
PDF file
MCMarcia Bastos Convento
Marcia Bastos Convento
EPEdson Pessoa
Edson Pessoa
AAAlef Aragão
Alef Aragão
NSNestor Schor
Nestor Schor
FBFernanda Teixeira Borges
Fernanda Teixeira Borges
Oxalate induces type II epithelial to mesenchymal transition (EMT) in inner medullary collecting duct cells (IMCD) in vitro and stimulate the expression of osteogenic and fibrotic markers in kidney medulla in vivo Oxalate induces type II epithelial to mesenchymal transition (EMT) in inner medullary collecting duct cells (IMCD) in vitro and stimulate the expression of osteogenic and fibrotic markers in kidney medulla in vivo

1 January 2021 in Clinics
Verified
Journal Article
Open access
CFCassiane Dezoti da Fonseca
Cassiane Dezoti da Fonseca
MWMirian Watanabe
Mirian Watanabe
SCSheila Marques Fernandes Couto
Sheila Marques Fernandes Couto
ASAlef Aragão Carneiro dos Santos
Alef Aragão Carneiro dos Santos
FBFernanda Teixeira Borges
Fernanda Teixeira Borges
MVMaria De Fatima Fernandes Vattimo
Maria De Fatima Fernandes Vattimo
Contrast-induced acute kidney injury (CI-AKI) is an important clinical problem that can be aggravated by diabetes mellitus, a major risk factor. However, heme oxygenase-1 (HO-1), a promising therapeutic target, can exert antioxidant effects against CI-AKI. ...

28 September 2024 in Cells
Verified
Journal Article
Open access
PDF file
GGGabriela Mandú Gimenes
Gabriela Mandú Gimenes
JPJoice Naiara Bertaglia Pereira
Joice Naiara Bertaglia Pereira
ESEliane da Silva
Eliane da Silva
ASAlef Aragão Carneiro dos Santos
Alef Aragão Carneiro dos Santos
TRTHAIS MARTINS RODRIGUES
THAIS MARTINS RODRIGUES
RCRui Curi
Rui Curi
Diabetes mellitus is associated with changes in intestinal morphology and the enteric nervous system. We previously reported constipation in Goto-Kakizaki (GK) rats, a non-obese model for type 2 diabetes mellitus. Aim: The morpho-quantitative analysis of myenteric plexus neurons in the small and large intestines of 120-day-old male GK rats was investigated. Methods: The diabetes was confirmed by high fasting blood glucose levels. The myenteric plexus was evaluated through wholemount immunofluorescence. The morpho-quantitative analyses included evaluating neuronal density (neurons per ganglion) of the total neuronal population, the cholinergic and nitrergic subpopulations, and enteric glial cells per ganglion. The cell body area of 100 neurons per segment per animal was measured. Results: The total neurons and nitrergic subpopulation were unaltered in the GK rats’ small and large intestines. The cholinergic subpopulation exhibited decreased density in the three segments of the small intestine and an increased number in the proximal colon of the GK rats. The number of enteric glial cells increased in the ileum of the GK rats, which could indicate enteric gliosis caused by the intestinal inflammatory state. The area of the cell body was increased in the total neuronal population of the jejunum and ileum of the GK rats. Frequency histograms of the cell body area distribution revealed the contribution of cholinergic neurons to larger areas in the jejunum and nitrergic neurons in the ileum. Conclusion: The constipation previously reported in GK rats might be explained by the decrease in the density of cholinergic neurons in the small intestine of this animal model.

25 July 2025 in Shock
Verified
Journal Article
Open access
NHNaoki Hayase
Naoki Hayase
RCRohit R. Chari
Rohit R. Chari
ASAlef A.C. Dos Santos
Alef A.C. Dos Santos
YNYoshitaka Naito
Yoshitaka Naito
XHXuzhen Hu
Xuzhen Hu
RSRobert Alan Star
Robert Alan Star
Background: Bolus antithrombin III (AT) improved sepsis/organ dysfunction and survival in lipopolysaccharide/monomicrobial infusion pretreatment animal models; however, AT failed in clinical trials. Because insults and drug administration schedules differed between preclinical and clinical settings, we re-examined AT using a clinically relevant polymicrobial insult (cecal ligation and puncture, CLP) and a new method to continuously infuse AT after animals became ill. Methods: Mice were catheterized with saline-filled osmotic minipumps. During CLP surgery we inserted AT- or saline-containing minipumps. We created and validated a ~6 h delay between sepsis induction and treatment. We compared delayed, continuous AT infusion with a conventional bolus AT injection using survival studies and 48-h studies. Results: 6-h delayed, continuous AT infusion significantly improved 7-d survival versus saline infusion (65% vs. 29%, n = 21, P = 0.018) and versus a single injection of AT (65% vs. 19%, n = 21, P = 0.003). Delayed, continuous AT attenuated liver but not kidney or lung injury. Vascular leakage and inflammatory cytokines were suppressed only in liver. The highest accumulation of bacteria and thrombin at 48 h was in liver. AT did not change organ bacterial counts. Conclusions: Delayed, continuous AT infusion improved 7-d survival after CLP compared to single bolus AT injection or continuous vehicle. Liver may be critical in abdominal sepsis because of bacterial accumulation and subsequent thrombin generation. AT may be protective due to attenuation of thrombin-induced vascular leakage, inflammation, and liver injury during CLP sepsis. Because other organs were unprotected, AT may be combined with drugs protecting different organs.

1 December 2019 in Brazilian Journal of Nephrology
Verified
Journal Article
Open access
PDF file
ACAgnaldo Caires
Agnaldo Caires
MCMarcia Bastos Convento
Marcia Bastos Convento
BCBianca Castino
Bianca Castino
ALAla Moana Leme
Ala Moana Leme
EPEdson de Andrade Pessoa
Edson de Andrade Pessoa
FBFernanda Teixeira Borges
Fernanda Teixeira Borges
Hypertension and Diabetes mellitus are the two main causes of chronic kidney disease that culminate in the final stage of kidney disease. Since these two risk factors are common and can overlap, new approaches to prevent or treat them are needed. Macitentan (MAC) is a new non-selective antagonist of the endothelin-1 (ET-1) receptor. This study aimed to evaluate the effect of chronic blockade of ET-1 receptor with MAC on the alteration of renal function observed in hypertensive and hyperglycemic animals. Genetically hypertensive rats were divided into control hypertensive (HT-CTL) group, hypertensive and hyperglycemic (HT+DIAB) group, and hypertensive and hyperglycemic group that received 25 mg/kg macitentan (HT-DIAB+MAC25) via gavage for 60 days. Kidney function and parameters associated with oxidative and nitrosative stress were evaluated. Immunohistochemistry for neutrophil gelatinase-associated lipocalin (NGAL), ET-1, and catalase in the renal cortex was performed. The HT+DIAB group showed a decrease in kidney function and an increase in NGAL expression in the renal cortex, as well as an increase in oxidative stress. MAC treatment was associated with attenuated ET-1 and NGAL production and increases in antioxidant defense (catalase expression) and nitric oxide production. In addition, MAC prevented an increase in oxidant injury (as measured by urinary hydroperoxide and lipid peroxidation), thus improving renal function. Our results suggest that the antioxidant effect of the ET-1 receptor antagonist MAC is involved in the improvement of kidney function observed in hypertensive and hyperglycemic rats.